atropine has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SH; Shin, SY; Yum, HR | 1 |
| Kurihara, T; Negishi, K; Shinojima, A; Tsubota, K | 1 |
| Chen, LJ; Kam, KW; Pang, CP; Tham, CC; Yam, JC; Zhang, XJ | 1 |
| Callisto, S; Chan, WO; Taranath, D; Usmani, E | 1 |
| Garg, H | 1 |
| Erdinest, N; Lavy, I; Levinger, N; London, N; Morad, Y; Pras, E | 1 |
1 review(s) available for atropine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Multiple Factors Causing Myopia and the Possible Treatments: A Mini Review.
Topics: Atropine; COVID-19; Disease Progression; Humans; Myopia; Ophthalmic Solutions | 2022 |
5 other study(ies) available for atropine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine.
Topics: Adolescent; Atropine; Child; Communicable Disease Control; Computers; COVID-19; Humans; Myopia; Ophthalmic Solutions; Pandemics; Republic of Korea; Retrospective Studies; Risk Factors; Smartphone | 2021 |
Myopia control and prevention: From lifestyle to low-concentration atropine. The 2022 Josh Wallman Memorial Lecture.
Topics: Atropine; Child; COVID-19; Disease Progression; Humans; Life Style; Mydriatics; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular | 2023 |
Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic.
Topics: Adolescent; Atropine; Australia; Axial Length, Eye; Child; COVID-19; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular; Retrospective Studies | 2023 |
Can glycopyrrolate come to the airway rescue in Covid-19 patients?
Topics: Atropine; Betacoronavirus; Coronavirus Infections; COVID-19; Glycopyrrolate; Humans; Intubation, Intratracheal; Pandemics; Pneumonia, Viral; Premedication; SARS-CoV-2 | 2020 |
Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; Communicable Disease Control; COVID-19; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular; Retrospective Studies | 2022 |